How effective is Benicar Hct for Low Blood Pressure (Hypotension) ?

Summary

Overall ratings: 4.2/5
Long term ratings: 4.3/5

This is a reivew of how effective Benicar hct (hydrochlorothiazide; olmesartan medoxomil) is for Low blood pressure and for what kind of people. The study is created by eHealthMe from 6 Benicar hct users and is updated continuously.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on hydrochlorothiazide; olmesartan medoxomil (the active ingredients of Benicar hct) and Benicar hct (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Benicar hct?

Benicar hct has active ingredients of hydrochlorothiazide; olmesartan medoxomil. It is often used in high blood pressure. (latest outcomes from Benicar hct 7,407 users)

What is Low blood pressure?

Low blood pressure has been reported by people with high blood pressure, multiple sclerosis, pain, primary pulmonary hypertension, rheumatoid arthritis (latest reports from 199,528 Low blood pressure patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 07, 2019

6 people are studied for taking Benicar hct in Low blood pressure


Overall effectiveness (number of people)

Does Benicar hct work for your Low blood pressure (overall)?

Long term effectiveness (number of people)

Does Benicar hct work for your Low blood pressure (long term)?

Benicar hct effectiveness for Low blood pressure (number of people)

Overall:
  • not at all: 0
  • somewhat: 0
  • moderate: 2
  • high: 1
  • very high: 3
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 1
  • high: 1
  • very high: 2

Gender of people who take Benicar hct for Low blood pressure *

  • female: 33.33 %
  • male: 66.67 %

Age of people who take Benicar hct for Low blood pressure *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 33.33 %
  • 60+: 66.67 %

Who finds Benicar Hct more effective for Low Blood Pressure?


Gender of people who take Benicar hct for Low blood pressure *

  • female: 50 %
  • male: 50 %

Age of people who take Benicar hct for Low blood pressure *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 50 %
  • 60+: 50 %

* Approximation only. Some reports may have incomplete information.


Do you take Benicar hct?

You are not alone:




Related studies:



Recent updates

Recent general studies
Recent personal studies


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.